{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:14:40Z","timestamp":1794507280314,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,20]],"date-time":"2027-03-20T00:00:00Z","timestamp":1805500800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["CA230890"],"award-info":[{"award-number":["CA230890"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["CA180067"],"award-info":[{"award-number":["CA180067"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007909","name":"Fibrolamellar Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD016240"],"award-info":[{"award-number":["S10 OD016240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1053\/j.gastro.2025.10.006","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:07:24Z","timestamp":1771319244000},"page":"787-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma"],"prefix":"10.1053","volume":"170","author":[{"given":"Jason A.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay K.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stephanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela R.","family":"Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Goodsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi L.","family":"Kenerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske J.E.","family":"van den Bijgaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa R.","family":"Farghli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Beirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Labadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Cernak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar Shahmir B.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mario","family":"Bello Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalyssa N.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Elz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Riehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeram","family":"Akilesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian N.","family":"Crispe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sethupathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-9643","authenticated-orcid":false,"given":"Venu G.","family":"Pillarisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.10.006_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000354698","article-title":"Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma","volume":"85","author":"Kaseb","year":"2013","journal-title":"Oncology"},{"key":"10.1053\/j.gastro.2025.10.006_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/XCS.0000000000000476","article-title":"Fibrolamellar hepatocellular carcinoma: comprehensive review of diagnosis, imaging, and management","volume":"236","author":"Aziz","year":"2023","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.gastro.2025.10.006_bib3","article-title":"Fibrolamellar carcinoma: an entity all its own","volume":"45","author":"O\u2019Neill","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"10.1053\/j.gastro.2025.10.006_bib4","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.3390\/cancers14215347","article-title":"Clinical outcomes in fibrolamellar hepatocellular carcinoma treated with immune checkpoint inhibitors","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.gastro.2025.10.006_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005620","article-title":"Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab","volume":"10","author":"Berger","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1053\/j.gastro.2025.10.006_bib6","first-page":"2056","article-title":"Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma","volume":"69","author":"Toni EN De","year":"2020","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000497464","article-title":"Progression after immunotherapy for fibrolamellar carcinoma","volume":"35","author":"Bauer","year":"2019","journal-title":"Visc Med"},{"key":"10.1053\/j.gastro.2025.10.006_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.18632\/oncotarget.2712","article-title":"The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients","volume":"6","author":"Darcy","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41575-022-00580-3","article-title":"A framework for fibrolamellar carcinoma research and clinical trials","volume":"19","author":"Dinh","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.006_bib10","first-page":"1010","article-title":"Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma","volume":"343","author":"Honeyman","year":"2014","journal-title":"Science (1979)"},{"key":"10.1053\/j.gastro.2025.10.006_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.semdp.2016.12.010","article-title":"Fibrolamellar carcinoma: a histologically unique tumor with unique molecular findings","volume":"34","author":"Graham","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.gastro.2025.10.006_bib12","doi-asserted-by":"crossref","first-page":"051","DOI":"10.1055\/s-0037-1621710","article-title":"Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms","volume":"38","author":"Lalazar","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2025.10.006_bib13","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1038\/s41467-022-33746-3","article-title":"The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma","volume":"13","author":"Bauer","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2025.10.006_bib14","article-title":"DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma","volume":"5","author":"Kirk","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1053\/j.gastro.2025.10.006_bib15","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1038\/s41598-024-55593-6","article-title":"Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade","volume":"14","author":"Daniel","year":"2024","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/2326-6066.CIR-18-0499","article-title":"Multiple immune-suppressive mechanisms in fibrolamellar carcinoma","volume":"7","author":"Kim","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.gastro.2025.10.006_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100574","article-title":"Protocol for tissue slice cultures from human solid tumors to study therapeutic response","volume":"2","author":"Kenerson","year":"2021","journal-title":"STAR Protoc"},{"key":"10.1053\/j.gastro.2025.10.006_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.21037\/atm.2019.12.88","article-title":"Tumor slice culture as a biologic surrogate of human cancer","volume":"8","author":"Kenerson","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.gastro.2025.10.006_bib19","article-title":"Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment","volume":"6","author":"Jiang","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.gastro.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4939-8885-3_20","article-title":"Establishment of slice cultures as a tool to study the cancer immune microenvironment","author":"Jiang","year":"2019","journal-title":"In: Methods in Molecular Biology. New York: Humana Press"},{"key":"10.1053\/j.gastro.2025.10.006_bib21","article-title":"Single-cell multi-omic analysis of fibrolamellar carcinoma reveals rewired cell-to-cell communication patterns and unique vulnerabilities","author":"Farghli","year":"2024","journal-title":"bioRxiv"},{"key":"10.1053\/j.gastro.2025.10.006_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55238-2","article-title":"Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma","volume":"15","author":"Requena","year":"2024","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajpath.2019.09.018","article-title":"Single-cell RNA sequencing identifies yes-associated protein 1\u2013dependent hepatic mesothelial progenitors in fibrolamellar carcinoma","volume":"190","author":"Jewell","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2025.10.006_bib24","article-title":"Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma","volume":"5","author":"Long","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1053\/j.gastro.2025.10.006_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011216","article-title":"DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma","volume":"20","author":"Ma","year":"2024","journal-title":"PLoS Genet"},{"key":"10.1053\/j.gastro.2025.10.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.073","article-title":"Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal candidate oncogenic pathways and therapeutic vulnerabilities","volume":"31","author":"Dinh","year":"2020","journal-title":"Cell Rep"},{"key":"10.1053\/j.gastro.2025.10.006_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep44653","article-title":"Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma","volume":"7","author":"Dinh","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/hep.27018","article-title":"Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature","volume":"59","author":"Malouf","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.10.006_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/onc.2015.139","article-title":"CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks","volume":"35","author":"Guo","year":"2016","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2025.10.006_bib30","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting CXCL12\/CXCR4 axis in tumor immunotherapy","volume":"26","author":"Zhou","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1053\/j.gastro.2025.10.006_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1053\/j.gastro.2025.10.006_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12 \/ CXCR4 \/ CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.gastro.2025.10.006_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/gutjnl-2023-329650","article-title":"Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours","volume":"72","author":"Dickerson","year":"2023","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.10.006_bib34","article-title":"Carcinomas assemble a filamentous CXCL12\u2013keratin-19 coating that suppresses T cell\u2013mediated immune attack","volume":"119","author":"Wang","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.gastro.2025.10.006_bib35","doi-asserted-by":"crossref","first-page":"28960","DOI":"10.1073\/pnas.2013644117","article-title":"CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response","volume":"117","author":"Biasci","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.gastro.2025.10.006_bib36","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti\u2013PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.gastro.2025.10.006_bib37","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/modpathol.2010.105","article-title":"Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation","volume":"23","author":"Ward","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.gastro.2025.10.006_bib38","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.gastro.2014.12.028","article-title":"Unique genomic profile of fibrolamellar hepatocellular carcinoma","volume":"148","author":"Cornella","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.10.006_bib39","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8+ T cells via CXCR4 blockade facilitates PD-1 checkpoint therapy in human pancreatic cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2025.10.006_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","article-title":"Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4","volume":"527","author":"Hatse","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1053\/j.gastro.2025.10.006_bib41","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-15-0262","article-title":"Evaluating robustness and sensitivity of the NanoString Technologies nCounter Platform to enable multiplexed gene expression analysis of clinical samples","volume":"75","author":"Veldman-Jones","year":"2015","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2025.10.006_bib42","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.gastro.2025.10.006_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.574667","article-title":"The Role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1053\/j.gastro.2025.10.006_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117534","article-title":"CXCL12\/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis","volume":"249","author":"Mortezaee","year":"2020","journal-title":"Life Sci"},{"key":"10.1053\/j.gastro.2025.10.006_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2025.10.006_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","article-title":"The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies","volume":"65","author":"Daniel","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.gastro.2025.10.006_bib47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein\u2013\u03b1","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1053\/j.gastro.2025.10.006_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426218122","article-title":"Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells","volume":"122","author":"Moresco","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"10.1053\/j.gastro.2025.10.006_bib49","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/leu.2011.62","article-title":"Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells","volume":"25","author":"Dar","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.gastro.2025.10.006_bib50","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2024.09.044","article-title":"CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma","volume":"82","author":"Lu","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.006_bib51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2025.10.006_bib52","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1716483114","article-title":"DNAJB1-PRKACA fusion kinase interacts with \u03b2-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma","volume":"114","author":"Kastenhuber","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2025.10.006_bib53","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/j.gastro.2017.09.008","article-title":"CRISPR\/Cas9 engineering of adult mouse liver demonstrates that the Dnajb1\u2013Prkaca gene fusion is sufficient to induce tumors resembling fibrolamellar hepatocellular carcinoma","volume":"153","author":"Engelholm","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.10.006_bib54","article-title":"Development of pre-clinical murine models for fibrolamellar hepatocellular carcinoma","author":"He","year":"2023","journal-title":"bioRxiv"},{"key":"10.1053\/j.gastro.2025.10.006_bib55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/2326-6066.CIR-24-0324","article-title":"Combination CXCR4 and PD-1 blockade enhances intratumoral dendritic cell activation and immune responses against hepatocellular carcinoma","volume":"13","author":"Morita","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.gastro.2025.10.006_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/2326-6066.CIR-25-0062","article-title":"Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunity","volume":"14","author":"Damle","year":"2026","journal-title":"Cancer Immunol Res"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525061219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525061219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:16:38Z","timestamp":1773998198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525061219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0016508525061219"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.10.006","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}